CBD is considered a medicine of high complexity in Andorra and can only be dispensed in hospital pharmacies. Cannabis is prohibited, though the government commissioned the law firm Roca Junyent for the creation of the draft law on the cultivation of cannabis – the aim of which is to regulate medical cannabis and its cultivation. It is still unclear when the bill will be introduced.
This report provides a summary of the current regulatory framework in place for CBD, hemp and cannabis in Andorra.
Laura Garay Gómez
Laura holds a Master’s degree in Public Law from the University of Seville, Spain, where she mainly specialised in International Law and Administrative Law. She has also studied International and European Law at the University of Helsinki, Finland, under the Erasmus Programme.
Our Key Benefits
The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
Start your FREE trial
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.